Achillion shareholders approve proposed $930M sale of company
December 20, 2019 at 11:46 AM EST
The Blue Bell company is being acquired by by a Connecticut drug developer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|